ANDEMBRY®, the first and only once-monthly treatment targeting factor XIIa to prevent attacks in HAE patients, inhibits plasma protein factor XIIa, which initiates the cascade of events leading to ...
Results of a retrospective case study revealed that the incidence of cutaneous pyogenic granuloma varies by age, sex, and anatomical location.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback